Kendrick, who tested positive for a banned stimulant, is seeking a reduced three-month ban which would expire before the tournament begins.

CAS will hear Kendrick’s case in New York on Aug. 18, and issue a verdict within days after the International Tennis Federation agreed to a fast-track process.

Kendrick tested positive for methylhexaneamine at the French Open on May 22.

The ITF banned the 31-year-old American for one year, despite his explanation that he took a capsule to combat jet lag.

Kendrick, whose ranking peaked at No. 69 two years ago, has dropped to No. 110.